A Maryland jury has convicted both former CytoDyn CEO Nader Pourhassan, Ph.D., and ex-Amarex CEO Kazem Kazempour on several charges tied to defrauding biotech investors. Pourhassan was found guilty of ...

Embattled CytoDyn and key ex-executives must face an investor lawsuit claiming the company knowingly misled shareholders about the status of its FDA application for leronlimab as a potential treatment ...

Nader Z. Pourhassan, PhD, the former CEO of CytoDyn, was sentenced yesterday to 30 months in prison, more than a year after he was convicted on charges that included four counts of securities fraud, ...

The former chief executive of CytoDyn, a Vancouver biotech firm, who once touted an experimental drug as a breakthrough treatment for HIV and COVID-19 was found guilty this week of lying to investors ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A federal jury in Maryland ...

Washington, D.C.--(Newsfile Corp. - December 20, 2022) - The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and insider trading in ...

The former CEO of Vancouver-based biotechnology company CytoDyn was sentenced Jan. 23 to 30 months in federal prison for defrauding investors, according to a news release from the Department of ...